Primary ciliary dyskinesia

Primary ciliary dyskinesia is a genetic disorder affecting motile cilia that impairs mucociliary clearance and leads to chronic respiratory disease. First described in clinical observations contemporaneous with work by Dr. Kartagener and others, it presents across pediatric and adult populations with recurrent infections and laterality defects. The condition intersects with research from institutions such as University of Oxford, Harvard Medical School, Johns Hopkins University, and Massachusetts General Hospital that collaborate with foundations like Cystic Fibrosis Foundation and American Thoracic Society on diagnostic standards.

Signs and symptoms

Patients typically present in infancy or childhood with chronic wet cough, recurrent otitis media, and persistent rhinosinusitis, findings also reported in cohorts studied at Great Ormond Street Hospital, Mayo Clinic, Seattle Children's Hospital, and Children's Hospital of Philadelphia. Neonatal respiratory distress and failure to clear secretions have been documented in case series from St Thomas' Hospital and Boston Children's Hospital. Laterality anomalies including situs inversus totalis and heterotaxy are described in literature from Guy's Hospital, King's College Hospital, Royal Brompton Hospital, and University College London Hospital; these anomalies are clinically significant in reports from Cleveland Clinic and Karolinska University Hospital. Infertility due to impaired sperm motility or dysfunctional fallopian tube cilia is reported by reproductive centers such as IVF Europe Clinic, Bourn Hall Clinic, and IVF Australia Clinic, with assisted reproductive consultations at University of California, San Francisco, Stanford Health Care, and Moorfields Eye Hospital for ocular surface manifestations. Clinical registries maintained by European Respiratory Society, National Institutes of Health, and European Cystic Fibrosis Society summarize comorbidities such as bronchiectasis observed in studies from Erasmus MC, University of Toronto, University of Sydney, and McGill University Health Centre.

Genetics and pathophysiology

Primary ciliary dyskinesia is genetically heterogeneous with causative variants in genes encoding dynein arms, radial spokes, and nexin links, first delineated by molecular studies at Max Planck Institute for Molecular Genetics, Wellcome Sanger Institute, Broad Institute, and European Molecular Biology Laboratory. Genes implicated include DNAH5 and DNAI1 identified in collaborative studies involving Columbia University, Yale University, University of Cambridge, and King's College London; additional loci such as CCDC39, CCDC40, RSPH4A, and LRRC6 were reported by consortia including Genomics England and 1000 Genomes Project investigators. High-throughput sequencing approaches developed at Illumina, Oxford Nanopore Technologies, and Pacific Biosciences have facilitated discovery pipelines used by groups at Cold Spring Harbor Laboratory, Sanger Institute, Broad Institute, and National Human Genome Research Institute. Pathophysiological mechanisms—disruption of outer and inner dynein arm function with consequent impaired ciliary beat frequency and pattern—are elucidated in laboratories at Max Planck Institute for Biophysical Chemistry, Institut Pasteur, University of Heidelberg, and University of Tokyo. Research into ciliary structure-function relationships cites foundational work linked to investigators associated with Nobel Prize-winning discoveries and to microscopy centers at Electron Microscopy Unit, University of Oxford, EMBL Grenoble, and NIH Clinical Center.

Diagnosis

Diagnostic evaluation integrates nasal nitric oxide measurement, high-speed video microscopy, transmission electron microscopy, and genetic testing, standardized by guidelines from European Respiratory Society, American Thoracic Society, British Thoracic Society, and panels convened at World Health Organization-affiliated meetings. Screening with nasal nitric oxide has been implemented in programs at Great Ormond Street Hospital, Royal Children's Hospital Melbourne, Hospital for Sick Children Toronto, and Nationwide Children's Hospital while confirmatory TEM studies have been reported from University Hospital Zurich, Hôpital Necker–Enfants Malades, Charité – Universitätsmedizin Berlin, and Rambam Health Care Campus. Next-generation sequencing panels developed at Mayo Clinic Laboratories, GeneDx, Invitae, and academic centers including Vanderbilt University Medical Center and University of Pennsylvania increase diagnostic yield. Differential diagnosis includes conditions investigated at specialty centers such as Cleveland Clinic and Johns Hopkins Hospital; multidisciplinary assessment often involves teams at Royal Brompton Hospital and Children's Hospital of Philadelphia.

Management and treatment

Treatment is multidisciplinary and borrows strategies from bronchiectasis and airway clearance programs at Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, Cystic Fibrosis Trust, and European Lung Foundation. Airway clearance techniques and physiotherapy protocols used at Texas Children's Hospital, University Hospital Southampton, and King's College Hospital reduce exacerbations. Antibiotic stewardship and culture-directed therapy informed by microbiology services at Centers for Disease Control and Prevention and Public Health England manage chronic infections with pathogens studied at Institut Pasteur, Wadsworth Center, and London School of Hygiene & Tropical Medicine. Otolaryngology interventions including tympanostomy and sinus surgery are performed at Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital. Fertility management and assisted reproduction are coordinated with clinics such as Bourn Hall Clinic, Guy's and St Thomas' NHS Foundation Trust, and UCLA Health. Emerging therapies and clinical trials reported by National Institutes of Health, European Commission Horizon 2020, NIHR, and pharmaceutical collaborations at Pfizer and Novartis focus on gene therapy, ciliary beat modulation, and novel antimicrobials.

Prognosis and complications

Long-term outcomes vary with genotype, access to care, and early intervention; longitudinal cohort studies from University of Copenhagen, Erasmus MC, University of Groningen, University of Antwerp, and Karolinska Institutet report progressive bronchiectasis, hearing loss, and reduced lung function. Complications include chronic colonization with Pseudomonas aeruginosa and nontuberculous mycobacteria documented by microbiology units at CDC and Public Health England, and surgical considerations mirror practices at Royal Brompton Hospital and Mayo Clinic. Quality of life and social outcomes have been assessed in multicenter studies coordinated by European Respiratory Society Youth Committee, Patient-Centered Outcomes Research Institute, and advocacy groups including Primary Ciliary Dyskinesia Foundation and Genetic Alliance. Research consortia at NIH and European Union continue to refine genotype–phenotype correlations and to evaluate interventions in randomized trials at centers such as Johns Hopkins Hospital and Great Ormond Street Hospital.

Category:Genetic disorders